XSpray Pharma AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About XSpray Pharma AB
XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.
/ 
Frequently asked questions
To buy XSpray Pharma AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for XSpray Pharma AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for XSpray Pharma AB is XSPRAY:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
XSpray Pharma AB has its primary listing on NASDAQ OMX Stockholm. You can trade XSpray Pharma AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, XSpray Pharma AB is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include XSpray Pharma AB as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like XSpray Pharma AB.